AliveCor announced today that it received FDA clearance for the next generation of its AI technology for the Kardia 12L ECG ...
Medical Device Network on MSN
AliveCor secures FDA approval for next-generation Kardia 12L ECG system
The newly cleared features include three rhythm modifiers and two axis-related morphology determinations: RAD and LAD.
AliveCor, the global leader in AI-powered cardiology, today announced it has received U.S. Food and Drug Administration (FDA) ...
While AliveCore faced two wins, the dispute did not end there. In March 2025, Apple triumphed in a major patent dispute with ...
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer .
HeartBeam has received FDA clearance for its synthesized 12-lead ECG software, making it the first cable-free device of its kind for at-home arrhythmia assessment. The clearance followed a successful ...
Company engaging in multiple options for a constructive resolution Strategy is underpinned by a clinical study that achieved the agreed upon endpoints Company believes that labeling modifications can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback